Decreased Interferon Signature of systemic lupus erythematosus patients after anti CD19 CAR T cell therapy

被引：0
|
作者：
Wilhelm, A. [1 ]
Chambers, D. [1 ]
Kroenke, G. [1 ]
Schett, G. [1 ]
机构：
[1] Univ Clin Erlangen, Erlangen, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O 65
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [31] Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
    Xuexiao Jin
    Qin Xu
    Chengfei Pu
    Kaixiang Zhu
    Cheng Lu
    Yu Jiang
    Lei Xiao
    Yongmei Han
    Linrong Lu
    Cellular & Molecular Immunology, 2021, 18 : 1896 - 1903
  • [32] Clinical implications for CAR T cell persistence and functional phenotype in patients treated with CD19 CAR T cell therapy.
    Bochnacka, Oliwia
    Quinn, Suzanne
    Dalheim, Annika
    Scurti, Gina
    Hossain, Nasheed
    Nishimura, Michael
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [33] Journal Club: Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus
    Boulougoura, Afroditi
    Gendelman, Hannah
    Surmachevska, Natalya
    Kyttaris, Vasileios C.
    ACR OPEN RHEUMATOLOGY, 2023, 5 (11) : 624 - 628
  • [34] CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
    Taubmann, Jule
    Mueller, Fabian
    Mutlu, Melek Yalcin
    Voelkl, Simon
    Aigner, Michael
    Bozec, Aline
    Mackensen, Andreas
    Grieshaber-Bouyer, Ricardo
    Schett, Georg
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (04) : 497 - 504
  • [35] Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
    Li, Qiang
    Yang, Zhihuan
    Fang, Kuo
    Wei, Shuning
    Sun, Jiali
    Liu, Wei
    Chen, Xiaojuan
    Huang, Wenyang
    Zhang, Guangji
    Shi, Yin
    Liu, Yuntao
    Gong, Xiaoyuan
    Liu, Fang
    Zhou, Xueli
    Wang, Jianxiang
    Wang, Ying
    BLOOD SCIENCE, 2023, 5 (01): : 62 - 65
  • [36] Paving the road ahead for CD19 CAR T-cell therapy
    Nellan, Anandani
    Lee, Daniel W.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 516 - 520
  • [37] Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus
    Kretschmann, S.
    Voelkl, S.
    Reimann, H.
    Kroenke, G.
    Schett, G.
    Achenbach, S.
    Lutzny-Geier, G.
    Mueller, F.
    Mougiakakos, D.
    Dingfelder, J.
    Flamann, C.
    Hanssens, L.
    Gary, R.
    Mackensen, A.
    Aigner, M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (01): : 27 - 33
  • [38] Correlation of pre-CAR CD19 expression with responses and relapses after CAR T cell therapy.
    Pillai, Vinodh
    Rosenthal, Jaclyn
    Muralidharan, Kavitha
    Wertheim, Gerald B.
    Paessler, Michele
    Maude, Shannon L.
    Rheingold, Susan R.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
    Hsieh, Emily M.
    Myers, Regina M.
    Yates, Bonnie
    Annesley, Colleen
    John, Samuel
    Taraseviciute, Agne
    Steinberg, Seth M.
    Sheppard, Jennifer
    Chung, Perry
    Chen, Lee
    Lee, Daniel W.
    DiNofia, Amanda
    Grupp, Stephan A.
    Verneris, Michael R.
    Laetsch, Theodore W.
    Bhojwani, Deepa
    Brown, Patrick A.
    Pulsipher, Michael A.
    Rheingold, Susan R.
    Gardner, Rebecca A.
    Gore, Lia
    Shah, Nirali N.
    Lamble, Adam J.
    BLOOD ADVANCES, 2022, 6 (17) : 5222 - 5226
  • [40] Significant association between CD19 polymorphism and systemic lupus erythematosus.
    Tokunaga, K
    Kuroki, K
    Tsuchiya, N
    Yamaguchi, A
    Tsao, BP
    Grossman, JM
    Fukazawa, T
    Hashimoto, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 353 - 353
12345